Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-06-14 @ 9:32 AM
Study NCT ID:
NCT00895960
Status:
TERMINATED
Last Update Posted:
2018-11-08
First Post:
2009-05-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Brain | View |
| None | CNS Disease | View |
| None | CNS | View |
| None | Intracranial Supratentorial GBM | View |
| None | Gliosarcoma | View |
| None | GS | View |
| None | Glioblastoma | View |
| None | GBM | View |
| None | Dasatinib | View |
| None | Sprycel | View |
| None | Temozolomide | View |
| None | TMZ | View |
| None | Temodar | View |
| None | Radiation Therapy | View |
| None | Radiotherapy | View |
| None | RT | View |